Cite
HARVARD Citation
Luo, M. et al. (2021). Exposure‐Response and Population Pharmacokinetic Analyses of a Novel Subcutaneous Formulation of Daratumumab Administered to Multiple Myeloma Patients. Journal of clinical pharmacology. pp. 614-627. [Online].